Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling is a **form of cell-to-cell communication in which one cell releases signaling molecules, such as growth factors or cytokines, that act on nearby cells to alter their behavior**[7]. This mechanism is critical for tissue repair, regeneration, and the coordination of cellular responses after injury. In the context of repair, paracrine factors released by cells—including stem cells—can stimulate proliferation, differentiation, angiogenesis, immune modulation, and other regenerative processes in neighboring cells[1][2][3][5][9]. Although not a single molecule, many medically important pathways (e.g., VEGF, FGF, cytokines) utilize paracrine signaling. *Paracrine signaling* itself is not a canonical drug target, but its components (paracrine factors and their receptors) are targets in therapeutic development, particularly in regenerative medicine and disease intervention[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling promoting repair.